Hjem › Lungekreft › South Carolina › Charleston
Kliniske studier for Lungekreft i Charleston, SC
11 studier for Lungekreft søker deltakere på steder i og rundt Charleston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RekruttererFase 3
- Ralph H Johnson VA Medical Center, Charleston
- Medical University of South Carolina, Charleston
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- Bon Secours Saint Francis Hospital, Charleston
- Medical University of South Carolina, Charleston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
RekruttererFase 3
- Medical University of South Carolina-Hollings Cancer Center ( Site 0045), Charleston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- Medical University of South Carolina, Charleston
Health Education Approach to Lung Screening
RekruttererFrivillige helsepersonell ønskes velkommen
- Medical University of South Carolina, Charleston
Prediction Augmented Screening Initiative
Rekrutterer
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- Ralph H Johnson VA Medical Center, Charleston
- Medical University of South Carolina, Charleston
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2/3
- Medical University of South Carolina, Charleston
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Medical University of South Carolina, Charleston
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
RekruttererObservasjonsstudie
- Medical University of South Carolina (MUSC), Charleston
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
RekruttererObservasjonsstudie
- Ralph H. Johnson VA Health Care System, Charleston
Lungekreft-studier i andre byer
- Houston, TX78 studier
- Boston, MA62 studier
- New York City, NY60 studier
- Los Angeles, CA45 studier
- Arlington, VA41 studier
- Washington, DC41 studier
- Chicago, IL41 studier
- Baltimore, MD40 studier
- Nashville, TN40 studier
- St. Louis, MO39 studier
- Columbus, OH37 studier
- Philadelphia, PA36 studier
Andre studier i Charleston
- Depresjon19 studier
- Slag18 studier
- Hjertesvikt18 studier
- Ikke-småcellet lungekreft16 studier
- Posttraumatisk stresslidelse16 studier
- Kardiovaskulær sykdom15 studier
- Prostatakreft15 studier
- Kreft (alle typer)14 studier
- Plateepitelcancer i hode og hals14 studier
- Parkinsons sykdom13 studier
- Interstitielle lungesykdommer13 studier
- Brystkreft12 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.